Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...
These medications were sitagliptin, liraglutide, glimepiride, or insulin glargine U-100. Sitagliptin, liraglutide, and ...
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...
Gov. Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost of the ...
Women with gestational diabetes rarely require insulin in the postpartum period. Patients with diet-controlled diabetes do not require monitoring of glucose levels after delivery. In patients who ...
The official spokesperson for the Ministry of Health and Population Hossam Abdel-Ghaffar announced details on the extended-release for the first locally produced batch of insulin “Glargine”, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback